WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Price
Valuation Score
Graham Fair Value
Graham Fair Value %
P/E
Forward P/E
P/S
P/B
PEG
Free Cash Flow
Free Cash Flow Yield
Book Value
BVPS
EV
EV/EBITDA
ICLR
ICON PLC
$304.14$137.85120.63%36.64x20.87x3.05x2.67x1.15x$1.17B4.66%$9.43B114.23$28.40B17.52
FONR
FONAR CORP
$16.09N/AN/A8.51xN/A1.01x0.66xN/A$12.25M11.82%$163.89M25.46$90.58M3.52
STRR
STAR EQUITY HOLDINGS INC
$0.93$22.88-95.93%0.58xN/A0.32x0.23x0.02x$3.23M22.23%$65.30M4.18-$582.32k-0.02
RVTY
REVVITY INC
$105.02$68.8552.54%18.89x15.20x4.72x1.65x0.96x$9.90M0.08%$7.87B63.73$16.09B12.92
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$232.10$189.5822.43%25.04x16.00x2.88x3.31x0.59x$365.37M3.07%$3.60B70.22$14.71B14.33
NEOG
NEOGEN CORP
$12.42$3.43262.30%621.00x19.71x2.90x0.86x1.31x-$12.98M-0.48%$3.15B14.53$3.42B18.11
QGEN
QIAGEN NV
$42.30$21.5096.76%28.20x16.96x4.91x2.54x1.12x$309.75M3.21%$3.81B16.69$10.49B15.24
TMO
THERMO FISHER SCIENTIFIC INC
$576.89$367.7156.89%37.17x21.30x5.20x4.71x0.71x$7.01B3.15%$46.74B121.08$246.82B22.32
IDXX
IDEXX LABORATORIES INC
$505.34$90.63457.58%49.69x45.57x11.47x28.28x5.08x$772.88M1.84%$1.48B17.87$42.58B34.97
A
AGILENT TECHNOLOGIES INC
$139.59$70.9696.72%33.08x23.23x6.07x6.61x1.02x$1.65B4.03%$6.19B21.12$41.71B24.68
ENZ
ENZO BIOCHEM INC
$1.06$23.75-95.54%1.58xN/A4.17x0.77x0.02x-$45.92M-85.75%$70.78M1.40$1.16M0.03
LH
LABORATORY CORP OF AMERICA HOLDINGS
$204.17$226.09-9.70%42.54x10.22x1.41x2.18x0.36x$874.10M5.09%$7.88B93.64$22.59B14.56
DGX
QUEST DIAGNOSTICS INC
$139.50$80.4073.50%18.53x15.82x1.67x2.41x1.25x$947.00M6.12%$6.43B57.95$20.38B11.96
MEDP
MEDPACE HOLDINGS INC
$400.21$56.17612.52%39.35x54.82x6.29x18.46x400.60x$473.34M3.83%$671.54M21.77$12.13B29.88
DHR
DANAHER CORP
$246.82$151.7462.66%41.41x21.15x8.12x3.42x0.73x$5.57B3.05%$53.44B72.16$193.95B25.73
CSTL
CASTLE BIOSCIENCES INC
$21.53N/AN/A-10.06x-9.92x2.63x1.51xN/A-$19.23M-3.33%$391.27M14.60$507.47M-11.27
SHC
SOTERA HEALTH CO
$11.38$30.76-63.00%63.22x9.25x3.05x7.25x0.13x-$362.71M-11.34%$443.73M1.58$5.24B12.89
TWST
TWIST BIOSCIENCE CORP
$32.03N/AN/A-8.87x-8.56x7.02x3.14xN/A-$128.84M-7.00%$590.04M10.26$1.68B-9.88
MTD
METTLER TOLEDO INTERNATIONAL INC
$1,255.24$534.83134.70%34.77x25.95x7.24x-179.81x1.30x$861.39M3.14%-$149.94M-6.86$28.97B24.71
WAT
WATERS CORP
$315.09$161.4195.21%28.99x21.61x6.30x16.22x1.08x$442.18M2.38%$1.15B19.47$20.70B20.68
SERA
SERA PROGNOSTICS INC
$11.15N/AN/A-9.61xN/A1,115.00x5.15xN/A-$27.01M-7.77%$70.16M2.25$358.95M-10.33
IQV
IQVIA HOLDINGS INC
$235.48$118.6098.55%31.86x19.40x2.89x6.99x1.06x$1.50B3.47%$6.11B33.25$55.26B16.97
NTRA
NATERA INC
$94.04N/AN/A-24.88x-29.85x9.99x14.84xN/A-$286.15M-2.65%$765.33M6.66$11.14B-29.08
XGN
EXAGEN INC
$1.41N/AN/A-1.05x-1.04x0.47x1.07xN/A-$15.27M-61.21%$22.69M1.28$11.04M-0.61
PRPO
PRECIPIO INC
$5.90N/AN/A-1.31xN/A0.50x0.58xN/A-$3.69M-48.12%$14.43M11.12$8.05M-1.86
PSNL
PERSONALIS INC
$1.36N/AN/A-0.60x-0.62x0.89x0.53xN/A-$67.17M-102.50%$129.44M2.69$50.02M-0.53
EXAS
EXACT SCIENCES CORP
$58.78N/AN/A-52.02x-26.01x4.24x3.39xN/A$31.93M0.30%$3.15B17.46$12.62B241.76
OLK
OLINK HOLDING AB (PUBL)
$23.35N/AN/A-93.40x467.00x17.12x5.78xN/A-$48.97M-1.69%$502.70M4.04$2.81B-140.13
FLGT
FULGENT GENETICS INC
$20.58N/AN/A-3.66x-26.73x2.12x0.54xN/A$5.57M0.91%$1.14B38.15$516.68M-3.85
DRIO
DARIOHEALTH CORP
$1.48N/AN/A-0.77x-0.76x2.06x0.75xN/A-$30.96M-73.72%$58.14M2.05$36.32M-0.67
ACRS
ACLARIS THERAPEUTICS INC
$1.22N/AN/A-0.96x-0.77x2.72x0.55xN/A-$79.63M-93.52%$157.18M2.25$47.08M-0.54
DMTK
DERMTECH INC
$0.60N/AN/A-0.19x-0.18x1.27x0.36xN/A-$77.88M-401.01%$57.18M1.75$34.79M-0.37
GH
GUARDANT HEALTH INC
$18.19N/AN/A-4.25x-3.60x3.61x13.95xN/A-$345.46M-16.96%$158.68M1.42$2.41B-5.55
STIM
NEURONETICS INC
$3.54N/AN/A-3.37x-4.11x1.42x3.08xN/A-$34.41M-33.97%$34.19M1.19$107.98M-4.74
NEO
NEOGENOMICS INC
$15.22N/AN/A-21.74x-30.44x3.23x2.06xN/A-$30.71M-1.61%$941.54M7.50$2.21B-264.14
BNR
BURNING ROCK BIOTECH LTD
$0.84N/AN/A-0.95x-1.10x1.15x0.81xN/A-$36.49M-42.53%$106.28M1.04$2.36M-0.03
OCX
ONCOCYTE CORP
$2.53N/AN/A-0.67x0.90x12.88x1.02xN/A-$23.25M-120.36%$20.47M2.68$12.63M-0.48
BGLC
BIONEXUS GENE LAB CORP
$0.60N/AN/A-3.28xN/A0.98x1.10xN/A-$1.45M-15.17%$9.66M0.61$8.12M-3.27
RDNT
RADNET INC
$49.00$13.88252.94%980.00x92.45x1.93x5.32x1.26x$44.35M1.42%$630.70M9.92$4.50B16.96
APDN
APPLIED DNA SCIENCES INC
$3.85N/AN/A-0.35x0.06x0.29x0.77xN/A-$7.67M-291.43%$4.23M6.19$276.67k-0.05
LAB
STANDARD BIOTOOLS INC
$2.48N/AN/A-2.64xN/A1.85x-4.86xN/A-$46.12M-23.51%-$148.05M-1.87$766.00M-11.67
PRE
PRENETICS GLOBAL LTD
$4.45N/AN/A-0.80x-7.42x2.30x0.26xN/AN/AN/A$206.36M18.35$10.57MN/A
XWEL
XWELL INC
$1.76N/AN/A-0.27xN/A0.24x0.57xN/A-$17.98M-244.66%$13.00M3.11$9.27M-0.38
CDNA
CAREDX INC
$8.20N/AN/A-2.32x-15.47x1.57x1.62xN/A-$26.73M-6.06%$261.33M4.86$370.08M-2.03
MDXH
MDXHEALTH SA
$2.50N/AN/A-0.15x-1.97x0.10x0.94xN/A-$24.24M-358.68%$7.21M2.67$91.80M-4.48
BDSX
BIODESIX INC
$1.22N/AN/A-1.91x-2.65x2.04x25.82xN/A-$45.93M-45.82%$4.58M0.06$152.68M-4.11
NDRA
ENDRA LIFE SCIENCES INC
$0.27N/AN/A-0.17xN/AN/A0.52xN/A-$9.57M-563.30%$5.66M0.89$507.02k-0.05
ME
23ANDME HOLDING CO
$0.52N/AN/A-0.46xN/A1.00x0.66xN/A-$194.26M-78.29%$377.19M0.78$84.19M-0.17
CHEK
CHECK-CAP LTD
$2.22N/AN/A-0.74x-0.93xN/A0.47xN/A-$17.74M-136.58%$27.40M4.68$9.50M-0.50
ULS
UL SOLUTIONS INC
$34.92N/AN/A26.86xN/A2.61xN/AN/A$252.00M3.61%$654.00M3.27N/AN/A
PRPH
PROPHASE LABS INC
$4.61N/AN/A-4.70x5.91x1.79x1.68xN/A-$14.46M-18.22%$49.38M2.87$102.42M-6.91
OPK
OPKO HEALTH INC
$1.24N/AN/A-4.96x-10.33x1.08x0.62xN/A-$41.76M-4.52%$1.39B1.85$1.08B-16.41
NOTV
INOTIV INC
$3.74N/AN/A-2.88xN/A0.16x0.38xN/A$6.48M6.71%$254.16M9.87$502.98M8.44
AWH
ASPIRA WOMEN's HEALTH INC
$3.33N/AN/A-1.84x-0.54x3.36x-17.38xN/A-$15.92M-51.77%-$2.37M-0.26$41.10M-2.49
VNRX
VOLITIONRX LTD
$0.86N/AN/A-1.72xN/A78.09x-9.04xN/A-$19.15M-31.32%-$7.80M-0.11$55.62M-1.65
MYGN
MYRIAD GENETICS INC
$19.80N/AN/A-6.23xN/A2.18x2.27xN/A-$184.20M-11.24%$783.20M9.46$1.80B-9.67
GENE
GENETIC TECHNOLOGIES LTD
$2.31N/AN/A-0.78xN/A0.08x0.17xN/A-$5.00M-1,124.59%$3.15M16.35-$1.65MN/A
ISPC
ISPECIMEN INC
$0.30N/AN/A-0.24xN/A0.27x0.28xN/A-$10.55M-390.30%$9.74M1.08$569.73k-0.06
BIAF
BIOAFFINITY TECHNOLOGIES INC
$2.53N/AN/A-2.78xN/A8.72x6.00xN/A-$6.06M-27.39%$4.86M0.56$27.89M-3.66
PMD
PSYCHEMEDICS CORP
$2.57N/AN/A-3.57xN/A0.67x2.21xN/A-$1.64M-11.09%$6.67M1.16$15.09M-19.65
ILMN
ILLUMINA INC
$124.73N/AN/A-16.99x21.47x4.38x3.45xN/A$283.00M1.44%$5.75B36.36$20.95B-34.45
MYNZ
MAINZ BIOMED NV
$0.87N/AN/A-0.54xN/A15.76x5.65xN/A-$23.84M-169.32%$3.25M0.20$17.67M-0.72
TRIB
TRINITY BIOTECH PLC
$1.78N/AN/AN/AN/A0.24x-0.57xN/AN/AN/A-$23.95M-3.12$64.81MN/A
MMA
ALTA GLOBAL GROUP LTD
$3.16N/AN/A-0.60xN/A21.07xN/AN/A-$5.92M-18.32%-$69.50M-6.80N/AN/A
CNTG
CENTOGENE NV
$0.46N/AN/A-0.29xN/A0.23x-0.77xN/A-$28.26M-222.61%-$16.55M-0.60$62.42M-1.41
TTOO
T2 BIOSYSTEMS INC
$2.94N/AN/A-0.15xN/A1.07x-0.58xN/A-$48.33M-629.83%-$28.04M-10.74$49.46M-1.16

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the top diagnostic & research stock with a Zen Score of 50, which is 22 points higher than the diagnostic & research industry average of 28. It passed 16 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 55.61% over the past year, overperforming other diagnostic & research stocks by 57 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 13.23% from Icon's current stock price of $304.14.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the second best diagnostic & research stock with a Zen Score of 47, which is 19 points higher than the diagnostic & research industry average of 28. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 1.64% over the past year, overperforming other diagnostic & research stocks by 3 percentage points.

3. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the third best diagnostic & research stock with a Zen Score of 46, which is 18 points higher than the diagnostic & research industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 33.57% over the past year, overperforming other diagnostic & research stocks by 35 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 3.03%, which is 2 percentage points higher than the diagnostic & research industry average of 1.35%.

Qiagen Nv's dividend payout ratio of 85.3% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.06%, which is 1 percentage points higher than the diagnostic & research industry average of 1.35%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.41%, which is the same as the diagnostic & research industry average of 1.35%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 60% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 1.22% in the last day, and up 4.07% over the last week. Quest Diagnostics was the among the top gainers in the diagnostics & research industry, gaining 3.9% yesterday.

Quest Diagnostics shares are trading higher. The FDA reportedly finalized its rules that aim to bring lab-developed tests in line with how it oversees other diagnostics.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 33.57% in the past year. It has overperformed other stocks in the diagnostic & research industry by 35 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -57.09% in the past year. It has underperformed other stocks in the diagnostic & research industry by -56 percentage points.

3. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Icon has a valuation score of 71, which is 50 points higher than the diagnostic & research industry average of 21. It passed 5 out of 7 valuation due diligence checks.

Icon's stock has gained 55.61% in the past year. It has overperformed other stocks in the diagnostic & research industry by 57 percentage points.

Are diagnostic & research stocks a good buy now?

47.92% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 9.47% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.74x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.